Modèles transgéniques pour l'étude de la fonction ... - Epublications

cells can simultaneously express cell surface kappa and lambda light chains. J Exp Med 178, 139-
49.
Pelanda, R., Schwers, S., Sonoda, E., Torres, R. M., Nemazee, D. and Rajewsky, K.
(1997). Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell
tolerance and antibody diversification. Immunity 7, 765-75.
Perlot, T., Alt, F. W., Bassing, C. H., Suh, H. and Pinaud, E. (2005). Elucidation of
IgH intronic enhancer functions via germ-line deletion. Proc Natl Acad Sci U S A 102, 14362-7.
Perrimon, N. and Bernfield, M. (2000). Specificities of heparan sulphate proteoglycans
in developmental processes. Nature 404, 725-8.
Perrimon, N. and Bernfield, M. (2001). Cellular functions of proteoglycans--an
overview. Semin Cell Dev Biol 12, 65-7.
Petersen-Mahrt, S. K., Harris, R. S. and Neuberger, M. S. (2002). AID mutates E. coli
suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103.
Petersen, S., Casellas, R., Reina-San-Martin, B., Chen, H. T., Difilippantonio, M. J.,
Wilson, P. C., Hanitsch, L., Celeste, A., Muramatsu, M., Pilch, D. R. et al. (2001). AID is
required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching.
Nature 414, 660-5.
Peterson, M. L. and Perry, R. P. (1986). Regulated production of mu m and mu s
mRNA requires linkage of the poly(A) addition sites and is dependent on the length of the mu smu
m intron. Proc Natl Acad Sci U S A 83, 8883-7.
Petitou, M., Lormeau, J. C. and Choay, J. (1988). Interaction of heparin and
antithrombin III. The role of O-sulfate groups. Eur J Biochem 176, 637-40.
Petro, J. B., Gerstein, R. M., Lowe, J., Carter, R. S., Shinners, N. and Khan, W. N.
(2002). Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen
receptor signaling. J Biol Chem 277, 48009-19.
Pfisterer, P., Annweiler, A., Ullmer, C., Corcoran, L. M. and Wirth, T. (1994).
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific
activities. Embo J 13, 1654-63.
Pham, P., Bransteitter, R., Petruska, J. and Goodman, M. F. (2003). Processive AIDcatalysed
cytosine deamination on single-stranded DNA simulates somatic hypermutation.
Nature 424, 103-7.
Pierani, A., Heguy, A., Fujii, H. and Roeder, R. G. (1990). Activation of octamercontaining
promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and
requirement of an additional B-cell-specific component for optimal transcription of
immunoglobulin promoters. Mol Cell Biol 10, 6204-15.
Pierce, J. W., Gifford, A. M. and Baltimore, D. (1991). Silencing of the expression of
the immunoglobulin kappa gene in non-B cells. Mol Cell Biol 11, 1431-7.
Pike, B. L., Boyd, A. W. and Nossal, G. J. (1982). Clonal anergy: the universally
anergic B lymphocyte. Proc Natl Acad Sci U S A 79, 2013-7.
Pillai, S., Cariappa, A. and Moran, S. T. (2004). Positive selection and lineage
commitment during peripheral B-lymphocyte development. Immunol Rev 197, 206-18.
Pinaud, E., Khamlichi, A. A., Le Morvan, C., Drouet, M., Nalesso, V., Le Bert, M.
and Cogne, M. (2001). Localization of the 3' IgH locus elements that effect long-distance
regulation of class switch recombination. Immunity 15, 187-99.
Poe, J. C., Fujimoto, Y., Hasegawa, M., Haas, K. M., Miller, A. S., Sanford, I. G.,
Bock, C. B., Fujimoto, M. and Tedder, T. F. (2004). CD22 regulates B lymphocyte function in
vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol 5, 1078-
87.
170